The global market for Infectious Disease Diagnostic Testing was estimated to be worth US$ 16500 million in 2023 and is forecast to a readjusted size of US$ 21090 million by 2030 with a CAGR of 3.5% during the forecast period 2024-2030

Infectious Disease Diagnostic Testing - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infectious Disease Diagnostic Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infectious Disease Diagnostic Testing by region & country, by Type, and by Application.

The Infectious Disease Diagnostic Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Diagnostic Testing.

Market Segmentation

Scope of Infectious Disease Diagnostic Testing - Market Report

Report Metric	Details
Report Name	Infectious Disease Diagnostic Testing - Market
Forecasted market size in 2030	US$ 21090 million
CAGR	3.5%
Forecasted years	2024 - 2030
Segment by Type:	Molecular Diagnostic Test POC Infectious Disease Diagnostics Test
Segment by Application	HIV HAIs Respiratory Tropical Diseases Liver Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, bioMerieux, Diasorin, Roche Diagnostic, BD, Gold Standard Diagnostics, Hologic, Siemens Healthcare Diagnostics, TECHLAB, Bio-Rad Laboratories, Corgenix, Cepheid, Meridian Bioscience
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Infectious Disease Diagnostic Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Infectious Disease Diagnostic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Infectious Disease Diagnostic Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Infectious Disease Diagnostic Testing - Market size in 2030?

Ans: The Infectious Disease Diagnostic Testing - Market size in 2030 will be US$ 21090 million.

Who are the main players in the Infectious Disease Diagnostic Testing - Market report?

Ans: The main players in the Infectious Disease Diagnostic Testing - Market are Abbott, bioMerieux, Diasorin, Roche Diagnostic, BD, Gold Standard Diagnostics, Hologic, Siemens Healthcare Diagnostics, TECHLAB, Bio-Rad Laboratories, Corgenix, Cepheid, Meridian Bioscience

What are the Application segmentation covered in the Infectious Disease Diagnostic Testing - Market report?

Ans: The Applications covered in the Infectious Disease Diagnostic Testing - Market report are HIV, HAIs, Respiratory, Tropical Diseases, Liver, Others

What are the Type segmentation covered in the Infectious Disease Diagnostic Testing - Market report?

Ans: The Types covered in the Infectious Disease Diagnostic Testing - Market report are Molecular Diagnostic Test, POC Infectious Disease Diagnostics Test

1 Market Overview

1.1 Infectious Disease Diagnostic Testing Product Introduction

1.2 Global Infectious Disease Diagnostic Testing Market Size Forecast

1.3 Infectious Disease Diagnostic Testing Market Trends & Drivers

1.3.1 Infectious Disease Diagnostic Testing Industry Trends

1.3.2 Infectious Disease Diagnostic Testing Market Drivers & Opportunity

1.3.3 Infectious Disease Diagnostic Testing Market Challenges

1.3.4 Infectious Disease Diagnostic Testing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Infectious Disease Diagnostic Testing Players Revenue Ranking (2023)

2.2 Global Infectious Disease Diagnostic Testing Revenue by Company (2019-2024)

2.3 Key Companies Infectious Disease Diagnostic Testing Manufacturing Base Distribution and Headquarters

2.4 Key Companies Infectious Disease Diagnostic Testing Product Offered

2.5 Key Companies Time to Begin Mass Production of Infectious Disease Diagnostic Testing

2.6 Infectious Disease Diagnostic Testing Market Competitive Analysis

2.6.1 Infectious Disease Diagnostic Testing Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Infectious Disease Diagnostic Testing Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostic Testing as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Molecular Diagnostic Test

3.1.2 POC Infectious Disease Diagnostics Test

3.2 Global Infectious Disease Diagnostic Testing Sales Value by Type

3.2.1 Global Infectious Disease Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Infectious Disease Diagnostic Testing Sales Value, by Type (2019-2030)

3.2.3 Global Infectious Disease Diagnostic Testing Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 HIV

4.1.2 HAIs

4.1.3 Respiratory

4.1.4 Tropical Diseases

4.1.5 Liver

4.1.6 Others

4.2 Global Infectious Disease Diagnostic Testing Sales Value by Application

4.2.1 Global Infectious Disease Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Infectious Disease Diagnostic Testing Sales Value, by Application (2019-2030)

4.2.3 Global Infectious Disease Diagnostic Testing Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Infectious Disease Diagnostic Testing Sales Value by Region

5.1.1 Global Infectious Disease Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Infectious Disease Diagnostic Testing Sales Value by Region (2019-2024)

5.1.3 Global Infectious Disease Diagnostic Testing Sales Value by Region (2025-2030)

5.1.4 Global Infectious Disease Diagnostic Testing Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Infectious Disease Diagnostic Testing Sales Value, 2019-2030

5.2.2 North America Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Infectious Disease Diagnostic Testing Sales Value, 2019-2030

5.3.2 Europe Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Infectious Disease Diagnostic Testing Sales Value, 2019-2030

5.4.2 Asia Pacific Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Infectious Disease Diagnostic Testing Sales Value, 2019-2030

5.5.2 South America Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Infectious Disease Diagnostic Testing Sales Value, 2019-2030

5.6.2 Middle East & Africa Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value

6.3 United States

6.3.1 United States Infectious Disease Diagnostic Testing Sales Value, 2019-2030

6.3.2 United States Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Infectious Disease Diagnostic Testing Sales Value, 2019-2030

6.4.2 Europe Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Infectious Disease Diagnostic Testing Sales Value, 2019-2030

6.5.2 China Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.5.3 China Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Infectious Disease Diagnostic Testing Sales Value, 2019-2030

6.6.2 Japan Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Infectious Disease Diagnostic Testing Sales Value, 2019-2030

6.7.2 South Korea Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Infectious Disease Diagnostic Testing Sales Value, 2019-2030

6.8.2 Southeast Asia Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Infectious Disease Diagnostic Testing Sales Value, 2019-2030

6.9.2 India Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.9.3 India Infectious Disease Diagnostic Testing Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Abbott

7.1.1 Abbott Profile

7.1.2 Abbott Main Business

7.1.3 Abbott Infectious Disease Diagnostic Testing Products, Services and Solutions

7.1.4 Abbott Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.1.5 Abbott Recent Developments

7.2 Abbott

7.2.1 Abbott Profile

7.2.2 Abbott Main Business

7.2.3 Abbott Infectious Disease Diagnostic Testing Products, Services and Solutions

7.2.4 Abbott Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.2.5 Abbott Recent Developments

7.3 bioMerieux

7.3.1 bioMerieux Profile

7.3.2 bioMerieux Main Business

7.3.3 bioMerieux Infectious Disease Diagnostic Testing Products, Services and Solutions

7.3.4 bioMerieux Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.3.5 Diasorin Recent Developments

7.4 Diasorin

7.4.1 Diasorin Profile

7.4.2 Diasorin Main Business

7.4.3 Diasorin Infectious Disease Diagnostic Testing Products, Services and Solutions

7.4.4 Diasorin Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.4.5 Diasorin Recent Developments

7.5 Roche Diagnostic

7.5.1 Roche Diagnostic Profile

7.5.2 Roche Diagnostic Main Business

7.5.3 Roche Diagnostic Infectious Disease Diagnostic Testing Products, Services and Solutions

7.5.4 Roche Diagnostic Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.5.5 Roche Diagnostic Recent Developments

7.6 BD

7.6.1 BD Profile

7.6.2 BD Main Business

7.6.3 BD Infectious Disease Diagnostic Testing Products, Services and Solutions

7.6.4 BD Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.6.5 BD Recent Developments

7.7 Gold Standard Diagnostics

7.7.1 Gold Standard Diagnostics Profile

7.7.2 Gold Standard Diagnostics Main Business

7.7.3 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Products, Services and Solutions

7.7.4 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.7.5 Gold Standard Diagnostics Recent Developments

7.8 Hologic

7.8.1 Hologic Profile

7.8.2 Hologic Main Business

7.8.3 Hologic Infectious Disease Diagnostic Testing Products, Services and Solutions

7.8.4 Hologic Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.8.5 Hologic Recent Developments

7.9 Siemens Healthcare Diagnostics

7.9.1 Siemens Healthcare Diagnostics Profile

7.9.2 Siemens Healthcare Diagnostics Main Business

7.9.3 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Products, Services and Solutions

7.9.4 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.9.5 Siemens Healthcare Diagnostics Recent Developments

7.10 TECHLAB

7.10.1 TECHLAB Profile

7.10.2 TECHLAB Main Business

7.10.3 TECHLAB Infectious Disease Diagnostic Testing Products, Services and Solutions

7.10.4 TECHLAB Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.10.5 TECHLAB Recent Developments

7.11 Bio-Rad Laboratories

7.11.1 Bio-Rad Laboratories Profile

7.11.2 Bio-Rad Laboratories Main Business

7.11.3 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Products, Services and Solutions

7.11.4 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.11.5 Bio-Rad Laboratories Recent Developments

7.12 Corgenix

7.12.1 Corgenix Profile

7.12.2 Corgenix Main Business

7.12.3 Corgenix Infectious Disease Diagnostic Testing Products, Services and Solutions

7.12.4 Corgenix Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.12.5 Corgenix Recent Developments

7.13 Cepheid

7.13.1 Cepheid Profile

7.13.2 Cepheid Main Business

7.13.3 Cepheid Infectious Disease Diagnostic Testing Products, Services and Solutions

7.13.4 Cepheid Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.13.5 Cepheid Recent Developments

7.14 Meridian Bioscience

7.14.1 Meridian Bioscience Profile

7.14.2 Meridian Bioscience Main Business

7.14.3 Meridian Bioscience Infectious Disease Diagnostic Testing Products, Services and Solutions

7.14.4 Meridian Bioscience Infectious Disease Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.14.5 Meridian Bioscience Recent Developments

8 Industry Chain Analysis

8.1 Infectious Disease Diagnostic Testing Industrial Chain

8.2 Infectious Disease Diagnostic Testing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Infectious Disease Diagnostic Testing Sales Model

8.5.2 Sales Channel

8.5.3 Infectious Disease Diagnostic Testing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Biomerieux

DiaSorin

Gold Standard Diagnostics

Hologic Inc

Siemens HealthCare Diagnostics

List of Tables

Table 1. Infectious Disease Diagnostic Testing Market Trends

Table 2. Infectious Disease Diagnostic Testing Market Drivers & Opportunity

Table 3. Infectious Disease Diagnostic Testing Market Challenges

Table 4. Infectious Disease Diagnostic Testing Market Restraints

Table 5. Global Infectious Disease Diagnostic Testing Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Infectious Disease Diagnostic Testing Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Infectious Disease Diagnostic Testing Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Infectious Disease Diagnostic Testing Product Type

Table 9. Key Companies Time to Begin Mass Production of Infectious Disease Diagnostic Testing

Table 10. Global Infectious Disease Diagnostic Testing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostic Testing as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Infectious Disease Diagnostic Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Infectious Disease Diagnostic Testing Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Infectious Disease Diagnostic Testing Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Infectious Disease Diagnostic Testing Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Infectious Disease Diagnostic Testing Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Infectious Disease Diagnostic Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Infectious Disease Diagnostic Testing Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Infectious Disease Diagnostic Testing Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Infectious Disease Diagnostic Testing Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Infectious Disease Diagnostic Testing Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Infectious Disease Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Infectious Disease Diagnostic Testing Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Infectious Disease Diagnostic Testing Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Infectious Disease Diagnostic Testing Sales Value by Region (2019-2024) & (%)

Table 27. Global Infectious Disease Diagnostic Testing Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value, (2025-2030) & (US$ Million)

Table 31. Abbott Basic Information List

Table 32. Abbott Description and Business Overview

Table 33. Abbott Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 34. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Abbott (2019-2024)

Table 35. Abbott Recent Developments

Table 36. Abbott Basic Information List

Table 37. Abbott Description and Business Overview

Table 38. Abbott Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 39. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Abbott (2019-2024)

Table 40. Abbott Recent Developments

Table 41. bioMerieux Basic Information List

Table 42. bioMerieux Description and Business Overview

Table 43. bioMerieux Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 44. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of bioMerieux (2019-2024)

Table 45. bioMerieux Recent Developments

Table 46. Diasorin Basic Information List

Table 47. Diasorin Description and Business Overview

Table 48. Diasorin Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 49. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Diasorin (2019-2024)

Table 50. Diasorin Recent Developments

Table 51. Roche Diagnostic Basic Information List

Table 52. Roche Diagnostic Description and Business Overview

Table 53. Roche Diagnostic Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 54. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Roche Diagnostic (2019-2024)

Table 55. Roche Diagnostic Recent Developments

Table 56. BD Basic Information List

Table 57. BD Description and Business Overview

Table 58. BD Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 59. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of BD (2019-2024)

Table 60. BD Recent Developments

Table 61. Gold Standard Diagnostics Basic Information List

Table 62. Gold Standard Diagnostics Description and Business Overview

Table 63. Gold Standard Diagnostics Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 64. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Gold Standard Diagnostics (2019-2024)

Table 65. Gold Standard Diagnostics Recent Developments

Table 66. Hologic Basic Information List

Table 67. Hologic Description and Business Overview

Table 68. Hologic Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 69. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Hologic (2019-2024)

Table 70. Hologic Recent Developments

Table 71. Siemens Healthcare Diagnostics Basic Information List

Table 72. Siemens Healthcare Diagnostics Description and Business Overview

Table 73. Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 74. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Siemens Healthcare Diagnostics (2019-2024)

Table 75. Siemens Healthcare Diagnostics Recent Developments

Table 76. TECHLAB Basic Information List

Table 77. TECHLAB Description and Business Overview

Table 78. TECHLAB Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 79. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of TECHLAB (2019-2024)

Table 80. TECHLAB Recent Developments

Table 81. Bio-Rad Laboratories Basic Information List

Table 82. Bio-Rad Laboratories Description and Business Overview

Table 83. Bio-Rad Laboratories Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 84. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Bio-Rad Laboratories (2019-2024)

Table 85. Bio-Rad Laboratories Recent Developments

Table 86. Corgenix Basic Information List

Table 87. Corgenix Description and Business Overview

Table 88. Corgenix Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 89. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Corgenix (2019-2024)

Table 90. Corgenix Recent Developments

Table 91. Cepheid Basic Information List

Table 92. Cepheid Description and Business Overview

Table 93. Cepheid Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 94. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Cepheid (2019-2024)

Table 95. Cepheid Recent Developments

Table 96. Meridian Bioscience Basic Information List

Table 97. Meridian Bioscience Description and Business Overview

Table 98. Meridian Bioscience Infectious Disease Diagnostic Testing Products, Services and Solutions

Table 99. Revenue (US$ Million) in Infectious Disease Diagnostic Testing Business of Meridian Bioscience (2019-2024)

Table 100. Meridian Bioscience Recent Developments

Table 101. Key Raw Materials Lists

Table 102. Raw Materials Key Suppliers Lists

Table 103. Infectious Disease Diagnostic Testing Downstream Customers

Table 104. Infectious Disease Diagnostic Testing Distributors List

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

Table 108. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Infectious Disease Diagnostic Testing Product Picture

Figure 2. Global Infectious Disease Diagnostic Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 4. Infectious Disease Diagnostic Testing Report Years Considered

Figure 5. Global Infectious Disease Diagnostic Testing Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Infectious Disease Diagnostic Testing Revenue in 2023

Figure 7. Infectious Disease Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Molecular Diagnostic Test Picture

Figure 9. POC Infectious Disease Diagnostics Test Picture

Figure 10. Global Infectious Disease Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Infectious Disease Diagnostic Testing Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of HIV

Figure 13. Product Picture of HAIs

Figure 14. Product Picture of Respiratory

Figure 15. Product Picture of Tropical Diseases

Figure 16. Product Picture of Liver

Figure 17. Product Picture of Others

Figure 18. Global Infectious Disease Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Infectious Disease Diagnostic Testing Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Infectious Disease Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Infectious Disease Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Infectious Disease Diagnostic Testing Sales Value (%), (2019-2030)

Figure 31. United States Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 37. China Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 39. China Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 49. India Infectious Disease Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Infectious Disease Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 51. India Infectious Disease Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 52. Infectious Disease Diagnostic Testing Industrial Chain

Figure 53. Infectious Disease Diagnostic Testing Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024

Global Diagnostic Guidewire Market Research Report 2024

Point of Care Diagnostic and Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Rapid Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

High density Multiplexed Diagnostic Assays Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Electro Diagnostic Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Radiological Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Virus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Automated Clinical Diagnostic System Market Research Report 2024

Global In Vitro Diagnostics IVD Products and Test Market Research Report 2025

Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock Diagnostics Kits Market Insights Forecast to 2030

Global Pharmaceutical Products Testing Market Research Report 2025

Global Anti Infectives Market Research Report 2025

Laboratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

[email protected]

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

	
		OSZAR »